These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30038430)

  • 1. Cryopreservation of infectious Cryptosporidium parvum oocysts.
    Jaskiewicz JJ; Sandlin RD; Swei AA; Widmer G; Toner M; Tzipori S
    Nat Commun; 2018 Jul; 9(1):2883. PubMed ID: 30038430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation of infectious Cryptosporidium parvum oocysts achieved through vitrification using high aspect ratio specimen containers.
    Jaskiewicz JJ; Sevenler D; Swei AA; Widmer G; Toner M; Tzipori S; Sandlin RD
    Sci Rep; 2020 Jul; 10(1):11711. PubMed ID: 32678171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable cryopreservation of infectious Cryptosporidium hominis oocysts by vitrification.
    Jaskiewicz JJ; Dayao DAE; Girouard D; Sevenler D; Widmer G; Toner M; Tzipori S; Sandlin RD
    PLoS Pathog; 2023 Jun; 19(6):e1011425. PubMed ID: 37289815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of viability and infectivity of Cryptosporidium parvum oocysts stored in potassium dichromate solution and chlorinated tap water.
    Chen F; Huang K; Qin S; Zhao Y; Pan C
    Vet Parasitol; 2007 Nov; 150(1-2):13-7. PubMed ID: 17954011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for the cryopreservation of Cryptosporidium isolates using enteroids.
    Deng M; Wei Y; Li N; Xiao L; Feng Y; Guo Y
    STAR Protoc; 2024 Jun; 5(2):103101. PubMed ID: 38824642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts.
    Jenkins MB; Anguish LJ; Bowman DD; Walker MJ; Ghiorse WC
    Appl Environ Microbiol; 1997 Oct; 63(10):3844-50. PubMed ID: 9327547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low temperatures on viability of Cryptosporidium parvum oocysts.
    Fayer R; Nerad T
    Appl Environ Microbiol; 1996 Apr; 62(4):1431-3. PubMed ID: 8919806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice.
    von Oettingen J; Nath-Chowdhury M; Ward BJ; Rodloff AC; Arrowood MJ; Ndao M
    Parasitology; 2008 Sep; 135(10):1151-6. PubMed ID: 18667105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
    Zhang X; Kim CY; Worthen T; Witola WH
    Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical comparison of excystation methods in Cryptosporidium parvum oocysts.
    Pecková R; Stuart PD; Sak B; Květoňová D; Kváč M; Foitová I
    Vet Parasitol; 2016 Oct; 230():1-5. PubMed ID: 27884435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved in vitro infection model for viability testing of Cryptosporidium parvum oocysts.
    Najdrowski M; Joachim A; Daugschies A
    Vet Parasitol; 2007 Nov; 150(1-2):150-4. PubMed ID: 17949908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time and temperature effects on the viability and infectivity of Cryptosporidium parvum oocysts in chlorinated tap water.
    Li X; Brasseur P; Agnamey P; Ballet JJ; Clemenceau C
    Arch Environ Health; 2004 Sep; 59(9):462-6. PubMed ID: 16381487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal-mouse infectivity of intact Cryptosporidium parvum oocysts isolated after optimized in vitro excystation.
    Hou L; Li X; Dunbar L; Moeller R; Palermo B; Atwill ER
    Appl Environ Microbiol; 2004 Jan; 70(1):642-6. PubMed ID: 14711704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous culture of Cryptosporidium parvum using hollow fiber technology.
    Morada M; Lee S; Gunther-Cummins L; Weiss LM; Widmer G; Tzipori S; Yarlett N
    Int J Parasitol; 2016 Jan; 46(1):21-9. PubMed ID: 26341006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Glycosaminoglycans on
    Mayerberger EA; Yazdanparast Tafti S; Jedlicka SS; Jellison KL
    Appl Environ Microbiol; 2023 Mar; 89(3):e0173722. PubMed ID: 36790186
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of time and temperature on flow cytometry enumerated live Cryptosporidium parvum oocysts.
    Ware MW; Schaefer FW
    Lett Appl Microbiol; 2005; 41(5):385-9. PubMed ID: 16238640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidium parvum oocyst viability and behaviour of the residual body during the excystation process.
    Kar S; Daugschies A; Cakmak A; Yilmazer N; Dittmar K; Bangoura B
    Parasitol Res; 2011 Dec; 109(6):1719-23. PubMed ID: 21603913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Models for Use in Cryptosporidium Infection Studies and Quantification of Parasite Burden Using Flow Cytometry, qPCR, and Histopathology.
    Sonzogni-Desautels K; Mead JR; Ndao M
    Methods Mol Biol; 2020; 2052():229-251. PubMed ID: 31452166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection.
    Joachim A; Eckert E; Petry F; Bialek R; Daugschies A
    Vet Parasitol; 2003 Jan; 111(1):47-57. PubMed ID: 12523978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.